Gastric ulcer after Endoscopic submucosal dissection
Conditions
Interventions
The control group:PPI
Experimental group One:PPI+Hydrotalcite Tablets
Experimental group Two:PPI+Weifuchun Capsule
Sponsors
The Affiliated Hospital of Hangzhou Normal University
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1. Age from 18 to 75, no gender limitation; 2. Endoscopic and CT evaluation required gastric ESD; 3. Gastric ESD postoperative wound <=25cm2; 4. Voluntarily agreed to participate in the study and signed informed consent.
Exclusion criteria
Exclusion criteria: 1. Patients with serious dysfunction of the liver, kidney, heart, lung, and other organs and diseases of cardiovascular system and endocrine system; 2. Mental abnormality, affecting the evaluation of clinical efficacy; 3. Pregnant and lactating women; 4. The presence of infectious diseases; 5. Those who are unable to give fully informed consent due to intellectual or behavioral disorders; 6. According to the judgment of the researcher, other lesions that reduce the possibility of inclusion or complicate inclusion, such as frequent changes in the work environment and other conditions that are easy to cause loss of follow-up; 7. Patients who are participating in clinical trials of other drugs.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| TCM Symptom Score; | — |
Secondary
| Measure | Time frame |
|---|---|
| Gastroscope;Pepsinogen;Gastrin-17; | — |
Countries
China
Contacts
Public ContactGuodong Li
The Affiliated Hospital of Hangzhou Normal University
Outcome results
None listed